Position in PLRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$63
+$2 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. PLRX ranks #365 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in PLRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63 | 50 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $61 | 50 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $74 | 50 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,701 | 2,329 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $47,858 | 35,451 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,131,038 | 85,880 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,045,130 | 93,232 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $862,429 | 80,226 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,063,114 | 71,350 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,252,667 | 69,170 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $306,951 | 17,702 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $446,404 | 24,636 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $35,697 | 1,342 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,426 | 229 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,044 | 433 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,867 | 358 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $15,527 | 2,215 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $144,693 | 10,718 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,544 | 210 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,215,643 | 41,746 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,221,274 | 31,052 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $356,748 | 15,702 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $182,151 | 8,042 | Shares | Defined | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||